Core Viewpoint - The company has announced the establishment of an industrial fund to enhance strategic development and capitalize on investment opportunities in the biopharmaceutical sector [1] Group 1: Investment Details - The company will collaborate with Guangzhou Nanyue Aoyang Fund Management Co., Ltd. and Guangzhou Nanyue Fund Group Co., Ltd. to set up the Guangzhou Zengcheng Nante Biopharmaceutical Investment Partnership (Limited Partnership) [1] - The total investment amount for the industrial fund is RMB 50.01 million, with the company contributing RMB 25 million, accounting for 49.99% of the total subscription [1] - The fund will primarily invest in early and mid-stage biopharmaceutical projects [1] Group 2: Regulatory Compliance - The investment partnership has completed the filing procedures with the Asset Management Association of China and has obtained the Private Investment Fund Filing Certificate [1]
洁特生物:关于对外投资设立产业基金的进展公告